Skip to main content

Advertisement

Table 2 Blood pressure/hemoglobin/glucose and Lipids profile, and Bone mineral density before/after treatment in the comparative groups

From: Weight loss therapy for clinical management of patients with some atherosclerotic diseases: a randomized clinical trial

Study groups SBP, mmHg DBP, mmHg Hemoglobin, gram/L Glucose, mmol/L Cholesterol, mmol/L Triglycerol, gram/L BMD, Units
Conventional patient subgroup, n = 40 Before treatment 149.4 ± 3.4 94.8 ± 2.2 132.1 ± 2.2 6.40 ± 0.49 5.60 ± 0.1 2.15 ± 0.05 74.0 ± 2.9
After treatment 129.6 ± 3.5 93.1 ± 2.1 134.0 ± 2.4 5.27 ± 0.37 5.24 ± 0.16 1.92 ± 0.09 73.2 ± 1.6
Weight loss patient subgroup, n = 31 Before treatment 150.1 ± 3.9 99.3 ± 2.9 129.5 ± 2.67 6.42 ± 0.46 5.73 ± 0.13 2.31 ± 0.1 71.6 ± 2.79
After treatment 121.8 ± 2.1 81.6 ± 1.8 140.3 ± 1.6 4.37 ± 0.38 4.26 ± 0.15 1.62 ± 0.09 97.9 ± 2.8
P before and after treatment in Conventional patient subgroup = <0.001 0.289 0.281 0.036 0.031 0.015 0.405
P before and after treatment in Weight loss patient subgroup = <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
  1. Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; BMD, bone mineral density
  2. Data are presented as Means ± SE